Search research articles
Contact Us
Filters
Showing results (111-120 of 133) with videos related to
Page
of 14
Sort By:
Journal of the Society for Cardiovascular Angiography & Interventions
|
March 20, 2024
Sex-Related Differences in Patient Characteristics, Hemodynamics, and Outcomes of Cardiogenic Shock: INOVA-SHOCK Registry
Kelly C Epps, Behnam N Tehrani, Carolyn Rosner, et al.
Nature Medicine
|
December 13, 2016
Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease
Eunsil Hahm, Changli Wei, Isabel Fernandez, et al.
Journal of the American College of Cardiology
|
April 29, 2026
Aligning Coronary Stent Trial Enrollment With the U.S. Intended-Use Population: Implications of Site Selection
Wayne B Batchelor, Robert Califf, Roxana Mehran, et al.
Journal of the American College of Cardiology
|
July 24, 2010
National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities
W Frank Peacock, Eugene Braunwald, William Abraham, et al.
JACC. Heart Failure
|
April 13, 2020
Endpoints in Heart Failure Drug Development: History and Future
Mona Fiuzat, Naomi Lowy, Norman Stockbridge, et al.
The New England Journal of Medicine
|
April 14, 2017
Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure
Milton Packer, Christopher O'Connor, John J V McMurray, et al.
Journal of the American College of Cardiology
|
March 30, 2019
Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure: Individual Participant Meta-Analysis
Rod S Taylor, Sarah Walker, Neil A Smart, et al.
Nature Communications
|
February 7, 2026
Urinary clusterin as a biomarker of human kidney disease progression and response to the endothelin receptor antagonist atrasentan: An exploratory analysis from the SONAR trial
Wenjun Ju, Viji Nair, Priya Vart, et al.
European Journal of Heart Failure
|
October 17, 2022
Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum
Javed Butler, Muhammad Shariq Usman, Kevin J Anstrom, et al.
JACC. Heart Failure
|
January 6, 2026
Subgroups and Special Populations in Heart Failure Clinical Trials: Insights From the HFC-ARC Expert Consensus Panel
Vanessa Blumer, Biykem Bozkurt, Marvin A Konstam, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 133) with videos related to
Sort By:
Page
of 14
Journal of the Society for Cardiovascular Angiography & Interventions
|
March 20, 2024
Sex-Related Differences in Patient Characteristics, Hemodynamics, and Outcomes of Cardiogenic Shock: INOVA-SHOCK Registry
Kelly C Epps, Behnam N Tehrani, Carolyn Rosner, et al.
Nature Medicine
|
December 13, 2016
Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease
Eunsil Hahm, Changli Wei, Isabel Fernandez, et al.
Journal of the American College of Cardiology
|
April 29, 2026
Aligning Coronary Stent Trial Enrollment With the U.S. Intended-Use Population: Implications of Site Selection
Wayne B Batchelor, Robert Califf, Roxana Mehran, et al.
Journal of the American College of Cardiology
|
July 24, 2010
National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities
W Frank Peacock, Eugene Braunwald, William Abraham, et al.
JACC. Heart Failure
|
April 13, 2020
Endpoints in Heart Failure Drug Development: History and Future
Mona Fiuzat, Naomi Lowy, Norman Stockbridge, et al.
The New England Journal of Medicine
|
April 14, 2017
Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure
Milton Packer, Christopher O'Connor, John J V McMurray, et al.
Journal of the American College of Cardiology
|
March 30, 2019
Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure: Individual Participant Meta-Analysis
Rod S Taylor, Sarah Walker, Neil A Smart, et al.
Nature Communications
|
February 7, 2026
Urinary clusterin as a biomarker of human kidney disease progression and response to the endothelin receptor antagonist atrasentan: An exploratory analysis from the SONAR trial
Wenjun Ju, Viji Nair, Priya Vart, et al.
European Journal of Heart Failure
|
October 17, 2022
Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum
Javed Butler, Muhammad Shariq Usman, Kevin J Anstrom, et al.
JACC. Heart Failure
|
January 6, 2026
Subgroups and Special Populations in Heart Failure Clinical Trials: Insights From the HFC-ARC Expert Consensus Panel
Vanessa Blumer, Biykem Bozkurt, Marvin A Konstam, et al.
Page
of 14